DISPOSITION IN NORMAL VOLUNTEERS OF SODIUM AZODISALICYLATE, A POTENTIAL THERAPEUTIC AGENT IN INFLAMMATORY BOWEL-DISEASE

DISPOSITION IN NORMAL VOLUNTEERS OF SODIUM AZODISALICYLATE, A POTENTIAL THERAPEUTIC AGENT IN INFLAMMATORY BOWEL-DISEASE

Detaylı Bibliyografya
Asıl Yazarlar:	Willoughby, C, Aronson, J, Agback, H, Bodin, N, Andersson, E, Truelove, S
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	1981

Benzer Materyaller

Distribution and metabolism in healthy volunteers of disodium azodisalicylate, a potential therapeutic agent for ulcerative colitis.
Yazar:: Willoughby, C, ve diğerleri
Baskı/Yayın Bilgisi: (1982)

Disodium azodisalicylate in ulcerative colitis.
Yazar:: Jewell, D, ve diğerleri
Baskı/Yayın Bilgisi: (1981)

THE DISPOSITION AND METABOLISM OF SULPHASALAZINE (SALICYLAZOSULFAPYRIDINE) IN MAN
Yazar:: Khan, A, ve diğerleri
Baskı/Yayın Bilgisi: (1982)

Drugs as causative agents and therapeutic agents in inflammatory bowel disease
Yazar:: Phani Krishna Kondamudi, ve diğerleri
Baskı/Yayın Bilgisi: (2013-09-01)

The effect of nifedipine on the disposition of strontium gluconate used as a kinetic marker for calcium in healthy volunteers.
Yazar:: Moraes, M, ve diğerleri
Baskı/Yayın Bilgisi: (1991)

Extracellular Vesicles: Novel Potential Therapeutic Agents in Inflammatory Bowel Diseases
Yazar:: Irene Mignini, ve diğerleri
Baskı/Yayın Bilgisi: (2023-12-01)

Therapeutic efficacy of jeoryeong-tang in dextran sulfate sodium-induced mouse model of inflammatory bowel disease
Yazar:: Il-Woong Jang, ve diğerleri
Baskı/Yayın Bilgisi: (2025-01-01)

Therapeutic targets in inflammatory bowel disease
Yazar:: Daniela Fluxa, ve diğerleri
Baskı/Yayın Bilgisi: (2019-07-01)

Deciphering Microbial Composition in Patients with Inflammatory Bowel Disease: Implications for Therapeutic Response to Biologic Agents
Yazar:: Orazio Palmieri, ve diğerleri
Baskı/Yayın Bilgisi: (2024-06-01)

Is the Therapeutic Drug Monitoring of Anti-TNF Agents Necessary in Korean Inflammatory Bowel Disease Patients?
Yazar:: Chang Soo Eun
Baskı/Yayın Bilgisi: (2017-01-01)

Using systems medicine to identify a therapeutic agent with potential for repurposing in inflammatory bowel disease
Yazar:: Katie Lloyd, ve diğerleri
Baskı/Yayın Bilgisi: (2020-11-01)

Bicervical Normal Uterus with Normal Vagina and Anteroposterior Disposition of the Double Cervix
Yazar:: José Morales-Roselló, ve diğerleri
Baskı/Yayın Bilgisi: (2011-01-01)

The discovery of the foxglove as a therapeutic agent
Yazar:: Aronson, J
Baskı/Yayın Bilgisi: (1987)

Therapeutic Drug Monitoring in Inflammatory Bowel Disease
Yazar:: Manoel Alvaro de Freitas Lins Neto, ve diğerleri
Baskı/Yayın Bilgisi: (2023-12-01)

Therapeutic Oligonucleotides for Patients with Inflammatory Bowel Diseases
Yazar:: Marafini I, ve diğerleri
Baskı/Yayın Bilgisi: (2020-06-01)

Evolving Therapeutic Strategies in the Inflammatory Bowel Disease
Yazar:: Soo-Young Na, ve diğerleri
Baskı/Yayın Bilgisi: (2018-02-01)

Catechins and Their Therapeutic Benefits to Inflammatory Bowel Disease
Yazar:: Fei-Yan Fan, ve diğerleri
Baskı/Yayın Bilgisi: (2017-03-01)

Sodium phosphate solution as bowel preparation for outpatient diagnostic and therapeutic manipulations
Yazar:: N. V. Topchy, ve diğerleri
Baskı/Yayın Bilgisi: (2017-12-01)

Advances in biological agents in the treatment of inflammatory bowel disease
Yazar:: Na LI, ve diğerleri
Baskı/Yayın Bilgisi: (2022-08-01)

The Role of Biologics Agent in the Treatment of Inflammatory Bowel Disease
Yazar:: Tri Hapsoro Guno, ve diğerleri
Baskı/Yayın Bilgisi: (2017-12-01)

Therapeutic Potential of Triptolide as an Anti-Inflammatory Agent in Dextran Sulfate Sodium-Induced Murine Experimental Colitis
Yazar:: Bufu Tang, ve diğerleri
Baskı/Yayın Bilgisi: (2020-11-01)

Neurochemical studies in normal volunteers
Yazar:: Nutt, D, ve diğerleri
Baskı/Yayın Bilgisi: (1988)

Development of Ac2-26 Mesoporous Microparticle System as a Potential Therapeutic Agent for Inflammatory Bowel Diseases
Yazar:: Broering MF, ve diğerleri
Baskı/Yayın Bilgisi: (2024-04-01)

Translating immunology into therapeutic concepts for inflammatory bowel disease
Yazar:: Uhlig, HH, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Genetically engineered bacteria as inflammatory bowel disease therapeutics
Yazar:: Zhen-Ping Zou, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

Ferroptosis: A therapeutic opportunity of inflammatory bowel disease
Yazar:: Yulin Ye, ve diğerleri
Baskı/Yayın Bilgisi: (2024-04-01)

Endoscopic Therapeutic Approach for Dysplasia in Inflammatory Bowel Disease
Yazar:: Sung Noh Hong
Baskı/Yayın Bilgisi: (2017-09-01)

Inflammasome Regulation: Therapeutic Potential for Inflammatory Bowel Disease
Yazar:: Qiuyun Xu, ve diğerleri
Baskı/Yayın Bilgisi: (2021-03-01)

Editorial: Novel Therapeutic Approaches in Inflammatory Bowel Diseases
Yazar:: Giovanni Pallio
Baskı/Yayın Bilgisi: (2023-09-01)

Gut microbiome–based therapeutics in inflammatory bowel disease
Yazar:: Kelly A. Hu, ve diğerleri
Baskı/Yayın Bilgisi: (2023-04-01)

Nutritional approach as therapeutic manipulation in inflammatory bowel disease
Yazar:: Jin Young Yoon
Baskı/Yayın Bilgisi: (2019-10-01)

The Gut Microbiota in the Pathogenesis and Therapeutics of Inflammatory Bowel Disease
Yazar:: Tao Zuo, ve diğerleri
Baskı/Yayın Bilgisi: (2018-09-01)

The microbiota in inflammatory bowel disease: current and therapeutic insights
Yazar:: Lane ER, ve diğerleri
Baskı/Yayın Bilgisi: (2017-06-01)

THE DISPOSITION OF ORAL RUBIDIUM CHLORIDE IN ESSENTIAL-HYPERTENSION
Yazar:: Boon, N, ve diğerleri
Baskı/Yayın Bilgisi: (1982)

The dispositional effects of holidays on investor sentiment: Therapeutic and hygienic
Yazar:: Qing Liu, ve diğerleri
Baskı/Yayın Bilgisi: (2023-04-01)

CYP2B6*6 genotype specific differences in artemether‐lumefantrine disposition in healthy volunteers
Yazar:: Abdullahi, ST, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Comparable Bioavailability and Disposition of Pefloxacin in Patients with Cystic Fibrosis and Healthy Volunteers Assessed via Population Pharmacokinetics
Yazar:: Jürgen B. Bulitta, ve diğerleri
Baskı/Yayın Bilgisi: (2019-07-01)

THE EFFECT OF DIGOXIN ON THE INVIVO DISPOSITION OF AN ORAL LOAD OF RUBIDIUM CHLORIDE
Yazar:: Aronson, J, ve diğerleri
Baskı/Yayın Bilgisi: (1982)

Biosimilars to Antitumor Necrosis Factor Agents in Inflammatory Bowel Disease
Yazar:: Al Sulais E, ve diğerleri
Baskı/Yayın Bilgisi: (2020-01-01)

Respiratory burst activity of intestinal macrophages in normal and inflammatory bowel disease.
Yazar:: Mahida, Y, ve diğerleri
Baskı/Yayın Bilgisi: (1989)